LENSAR, Inc. (LNSR) Earnings Call Transcripts

16 earnings calls from November 2021 to May 8, 2026

NasdaqCM US Health Care Health Care Equipment and Supplies

LENSAR, Inc.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, LENSAR, Inc. reported total revenue of $13.4 million, a decline of 5% year-over-year, primarily due to lower system capital sales. However, recurring revenue grew by 9% to $12.6 million, representing 94% of total revenue, indicating strong underlying demand for its ALLY system. Management emphasized a shift towards rebuilding growth momentum and expanding the installed base, with a focus on increasing recurring revenue as they transition out of a merger-related holding pattern. The company did not provide specific guidance but expressed optimism for future growth as they reestablish their market position.

Reported metrics

MetricValueContext
Total Revenue $13.4 million (miss) vs $14.2 million in Q1 2025, -5% YoY
Recurring Revenue $12.6 million (beat) up 9% YoY from $11.5 million
Net Income $36.3 million (beat) vs net loss of $27.3 million in Q1 2025, largely driven by noncash items
Gross Margin 48% (miss) vs 50% in Q1 2025
Operating Expenses $4.1 million (beat) down from $12.9 million in Q1 2025
ALLY Installed Base 205 systems (positive) up from 193 systems YoY

Guidance from management

Management did not provide specific guidance but expressed optimism about returning to growth, particularly in recurring revenue and system placements as they rebuild their business post-merger termination.

What management said

That's post quarter end. It's going to take us -- just to very succinctly, it's going to take us the next couple of quarters. I really expect the next few quarters to be this like steady progress of rebuilding and improvement here. I think the really great story is that our recurring revenue is so strong and that it continues to grow. And I feel that's going to continue. So now as we start adding additional placement...
— Nicholas Curtis, Q1 FY2026 earnings call
So I was just going to address your procedure question, which is when you look at the procedure growth in the quarter, it is solely related to U.S. activity. So Nick and I can't -- I guess we can't emphasize enough that when the acquisition was announced, there was a slow turn-off of our distributor activity. And so you see that in not only procedure volume, but more importantly, in placements. And so right now, the ...
— Thomas Staab, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the pace of recovery in system placements and the impact of the terminated merger on future growth. There were questions regarding the timing of distributor re-engagement and the potential for operational expenses to increase as the company rebuilds its workforce.

Main topics on the call

Read the full LENSAR, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About LENSAR, Inc.

LENSAR, Inc. (LNSR) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 16 calls on record spanning November 8, 2021 to May 8, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 16 LENSAR, Inc. earnings call transcripts on record, spanning November 8, 2021 to May 8, 2026. Based on this history, LENSAR, Inc. reports quarterly. The most recent call on file is dated May 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LNSR
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Health Care Equipment and Supplies
Calls on record
16
First call
November 8, 2021
Most recent
May 8, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2026 May 8, 2026 Read transcript
Q4 FY2025 Mar 31, 2026 Read transcript
Q4 FY2024 Feb 27, 2025 Read transcript
Q3 FY2024 Nov 7, 2024 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Q1 FY2024 May 9, 2024 Read transcript
Q4 FY2023 Mar 4, 2024 Read transcript
Q3 FY2023 Nov 9, 2023 Read transcript
Q2 FY2023 Aug 9, 2023 Read transcript
Q1 FY2023 May 15, 2023 Read transcript
Q4 FY2022 Mar 16, 2023 Read transcript
Q3 FY2022 Nov 9, 2022 Read transcript
Q2 FY2022 Aug 8, 2022 Read transcript
Q1 FY2022 May 9, 2022 Read transcript
Q4 FY2021 Mar 3, 2022 Read transcript
Q3 FY2021 Nov 8, 2021 Read transcript